We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Transcription Regulation Depends on Release from Chromatin

By LabMedica International staff writers
Posted on 09 May 2018
Print article
Image: The long non-coding RNA called A-ROD is only functional the moment it is released from chromatin into the nucleoplasm. At this transient phase, it can bring transcription factors to specific sites in DNA to enhance gene expression. After its complete release from chromatin, A-ROD is no longer active (Photo courtesy of Evgenia Ntini, Max Planck Institute for Molecular Genetics).
Image: The long non-coding RNA called A-ROD is only functional the moment it is released from chromatin into the nucleoplasm. At this transient phase, it can bring transcription factors to specific sites in DNA to enhance gene expression. After its complete release from chromatin, A-ROD is no longer active (Photo courtesy of Evgenia Ntini, Max Planck Institute for Molecular Genetics).
A team of German genome researchers has demonstrated that release from chromatin is a crucial functional aspect of long noncoding RNAs in transcription regulation of their target genes.

Long non-coding RNAs (lncRNAs) are considered to be non-protein coding transcripts longer than 200 nucleotides. This somewhat arbitrary limit distinguishes lncRNAs from small regulatory RNAs such as microRNAs (miRNAs), short interfering RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), and other short RNAs. LncRNAs have been found to be involved in numerous biological roles including imprinting, epigenetic gene regulation, cell cycle and apoptosis, and metastasis and prognosis in solid tumors. Most lncRNAs are expressed only in a few cells rather than whole tissues, or they are expressed at very low levels, making them difficult to study. Their name notwithstanding, long non-coding RNAs (lncRNAs) have been found to actually encode synthesis of small polypeptides that can fine-tune the activity of critical cellular components. LncRNAs are often enriched in the nucleus and at chromatin, but whether their dissociation from chromatin is important for their role in transcription regulation is unclear.

To better understand the link between lncRNAs and chromatin, investigators at the Max Planck Institute for Molecular Genetics (Berlin, Germany) grouped lncRNAs using epigenetic marks, expression, and strength of chromosomal interactions.

They reported in the April 24, 2018, online edition of the journal Nature Communications that lncRNAs transcribed from loci engaged in strong long-range chromosomal interactions were less abundant at chromatin, suggesting the release from chromatin was a crucial functional aspect of lncRNAs in transcription regulation of their target genes.

To gain mechanistic insight into this mechanism, they functionally validated the lncRNA A-ROD, which enhances DKK1 (Dickkopf-related protein 1) transcription via its nascent spliced released form. Detailed validation provided evidence that the regulatory effect was exerted by A-ROD at its release from the chromatin-associated site of transcription.

These findings provide evidence that the regulatory interaction required dissociation of A-ROD from chromatin, with target specificity having been established during the period of chromosomal proximity.

Related Links:
Max Planck Institute for Molecular Genetics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more